The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus: The use of EQ-5D in Type 2 diabetes
Abstract
BACKGROUND: The EQ-5D is a generic preference-based health status measure that has been widely applied to measure the impact of Type 2 diabetes mellitus. This review summarizes evidence on the validity, reliability and responsiveness of the EQ-5D in studies of Type 2 diabetes and provides a catalogue of EQ-5D index scores for Type 2 diabetes and various complications and subgroups. METHODS: A structured search was conducted (1987-2009) using keywords relevant to Type 2 diabetes and the EQ-5D. Original research studies in Type 2 diabetes that reported EQ-5D results and/or measurement properties were included. RESULTS: Of the 59 included articles, 54 publications reported EQ-5D responses and 39 papers presented evidence on the measurement properties of the EQ-5D. Studies that reported measurement properties supported construct, convergent and discriminant validity, test-retest reliability and responsiveness of the EQ-5D in Type 2 diabetes. Several studies reported a ceiling effect for the EQ-5D and an inability to capture multiple complications was observed. EQ-5D index scores ranged from 0.20 (severe diabetic peripheral neuropathic pain) to 0.88 (general population: good HbA(1c) level). For six subgroups, sufficient studies were available to calculate pooled mean index scores (95% CI): general population 0.67 (0.59-0.75), no complications 0.76 (0.68-0.83), microvascular complications 0.73 (0.57-0.89), macrovascular complications 0.73 (0.57-0.88), diabetic peripheral neuropathic pain 0.45 (0.39-0.51) and retinopathy 0.57 (0.46-0.69). CONCLUSIONS: Evidence supported validity, reliability and responsiveness of the EQ-5D in Type 2 diabetes. EQ-5D index scores associated with Type 2 diabetes and various complications can be useful for modelling health outcomes in economic evaluations of health programmes for Type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Lifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515
Economic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Swedish population health-related quality of life results using the EQ-5D
Burström, K., Johannesson, M., & Diderichsen, F. (2001) · Quality of Life Research · doi:10.1023/a:1013171831202 · Cited by 664
Gore, M., Brandenburg, N. A., Dukes, E., Hoffman, D. L., Tai, K.-S., & Stacey, B. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.04.009 · Cited by 525
Comparison of the EQ-5D and SF-12 Health Surveys in a General Population Survey in Alberta, Canada
Johnson, J. A., & Pickard, A. S. (2000) · Medical Care · doi:10.1097/00005650-200001000-00013 · Cited by 274
Self-citationBurström, K., Johannesson, M., & Diderichsen, F. (2001) · Health Policy · doi:10.1016/s0168-8510(00)00111-1 · Cited by 244
Coping with Type II diabetes: the patient’s perspective
Koopmanschap, M. (2002) · Diabetologia · doi:10.1007/s00125-002-0861-2 · Cited by 158
Health utility values associated with diabetic retinopathy
Lloyd, A., Nafees, B., Gavriel, S., Rousculp, M. D., Boye, K. S., & Ahmad, A. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02430.x · Cited by 83
Cited by
Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets
van Hout, B., Janssen, M. F., Feng, Y.-S., Kohlmann, T., Busschbach, J., Golicki, D., Lloyd, A., Scalone, L., Kind, P., & Pickard, A. S. (2012) · Value in Health · doi:10.1016/j.jval.2012.02.008 · Cited by 2,153
Self-citationJanssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., Swinburn, P., & Busschbach, J. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0322-4 · Cited by 1,582
Self-citationValuing health-related quality of life: an EQ-5D-5L value set for England
Devlin, N. J., Shah, K. K., Feng, Y., Mulhern, B., & van Hout, B. (2018) · Health Economics · doi:10.1002/hec.3564 · Cited by 1,356
Psychometric properties of the EQ-5D-5L: a systematic review of the literature
Feng, Y.-S., Kohlmann, T., Janssen, M. F., & Buchholz, I. (2021) · Quality of Life Research · doi:10.1007/s11136-020-02688-y · Cited by 917
Self-citationA Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol
Oppe, M., Devlin, N. J., van Hout, B., Krabbe, P. F. M., & de Charro, F. (2014) · Value in Health · doi:10.1016/j.jval.2014.04.002 · Cited by 428
Metadata
- Authors
- Janssen, M. F., Lubetkin, E. I., Sekhobo, J. P., & Pickard, A. S.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2011-03-10
- Volume
- 28
- Issue
- 4
- Pages
- 395-413
- ISSN
- 0742-3071 (ISSN-L)
- OpenAlex
- W1888647731
- Cited by
- 164
- References
- 9
- FWCI
- 10.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus: The use of EQ-5D in Type 2 diabetes. https://app.cochat.ai/papers/10.1111/j.1464-5491.2010.03136.x
- The paper
- Janssen, M. F., Lubetkin, E. I., Sekhobo, J. P., & Pickard, A. S. (2011). The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus: The use of EQ-5D in Type 2 diabetes. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2010.03136.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.